Patients with prostate cancer who undergo prostatectomy or radiotherapy have a higher risk of long-term complications than untreated patients with prostate cancer.
It includes a seven times higher risk of urinary or sexual complications in men who had a prostatectomy compared with untreated men, the 12-year study found. For men first treated with radiotherapy, ...
Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced a significant milestone for both Theragent and its sponsor client, CellVax ...